메뉴 건너뛰기




Volumn 27, Issue 3, 2011, Pages 651-662

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension

(14)  Hyams, Jeffrey a   Walters, Thomas D b   Crandall, Wallace c   Kugathasan, Subra d   Griffiths, Anne b   Blank, Marion e   Johanns, Jewel e   Lang, Yinghua e   Markowitz, James f   Cohen, Stanley g   Winter, Harland S h   Veereman Wauters, Gigi i   Ferry, George j   Baldassano, Robert k,l  


Author keywords

Crohn's disease; Infliximab; Long term experience; Maintenance therapy; Pediatric; Tumor necrosis factor

Indexed keywords

INFLIXIMAB;

EID: 79951626926     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.547575     Document Type: Article
Times cited : (98)

References (13)
  • 2
    • 0025796809 scopus 로고
    • Development and validation ofapediatric Crohn's disease activity index
    • Hyams JS, Ferry GD, Mandel FS,et al. Development and validation ofapediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47
    • (1991) J Pediatr Gastroenterol Nutr , vol.12 , pp. 439-47
    • Hyams, J.S.1    Ferry, G.D.2    Mandel, F.S.3
  • 3
    • 0026525024 scopus 로고
    • Relationship of common laboratory parameters to the activity of Crohn's disease in children
    • Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-22
    • (1992) J Pediatr Gastroenterol Nutr , vol.14 , pp. 216-22
    • Hyams, J.S.1    Mandel, F.2    Ferry, G.D.3
  • 7
    • 79951668209 scopus 로고    scopus 로고
    • National Center for Health Statistics, Available at [Last accessed 23 August 2010]
    • National Center for Health Statistics. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/nchs/about/major/nhanes/ growthcharts/zscore/zscore.htm [Last accessed 23 August 2010]
  • 8
    • 69949117363 scopus 로고    scopus 로고
    • Mechanisms of growth impairment in pediatric Crohn's disease [review]
    • Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease [review]. Nat Rev Gastroenterol Hepatol 2009;6:513-23
    • (2009) Nat Rev Gastroenterol Hepatol , vol.6 , pp. 513-23
    • Walters, T.D.1    Griffiths, A.M.2
  • 12
    • 57149094224 scopus 로고    scopus 로고
    • Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: Results of the REACH study
    • Thayu M, Leonard MB, Hyams JS, et al. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. Clin Gastroenterol Hepatol 2008;6:1378-84
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1378-84
    • Thayu, M.1    Leonard, M.B.2    Hyams, J.S.3
  • 13
    • 67650234230 scopus 로고    scopus 로고
    • Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
    • Hyams JS, Lerer T, Griffiths A, et al. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis 2009; 15:816-22
    • (2009) Inflamm Bowel Dis , vol.15 , pp. 816-22
    • Hyams, J.S.1    Lerer, T.2    Griffiths, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.